Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

In Vitro Comparative Effect of Carbetocin and Oxytocin in Pregnant Human Myometrium With and Without Oxytocin Pretreatment

Cole, N.M.; Carvalho, J.C.; Erik-Soussi, M.; Ramachandran, N.; Balki, M.

doi: 10.1097/01.aoa.0000504719.68344.63
Epidemiologic Reports Surveys
Buy
Commentary

(Anesthesiology 2016;124:378–386)

Oxytocin remains the first-line uterotonic agent for the prevention and treatment of postpartum hemorrhage (PPH) secondary to uterine atony, but its routine use has limitations that include many side effects. Hence there is a search for newer agents for the prevention of PPH with greater efficacy and fewer side effects. The objective of this study was to compare the effects of oxytocin and carbetocin in human term pregnant myometrium in vitro, with and without oxytocin pretreatment.

Department of Anesthesia and Pain Management and Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved